MECP2 and pancreatic neoplasm: By using DNA methylase inhibitors which downregulate DNA methylation level, the transcriptional suppression effects of Mecp2 were reversed in pancreatic cancer cell lines and hepatic stellate cells 53-55, which indirectly suggest MBD as a key domain for gene suppression.